US Edition
News about Wegovy
Stay current with all the latest and breaking news about Wegovy, compare headlines and perspectives between news sources on stories happening today. In total, 142 stories have been published about Wegovy which Ground News has aggregated in the past 3 months.
Covered Most By
Local News Publishers
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Wegovy News
WegovyMove over Ozempic, Wegovy, Mounjaro and Zepbound — Eli Lilly says another contender may be on the way. The pharmaceutical giant announced encouraging results from a Phase 3 clinical trial of its experimental weight loss drug retatrutide, showing levels of weight loss that could rival — or exceed — existing blockbuster treatments. What the study found According to Eli Lilly, patients taking retatrutide lost nearly 30% of their body weight over 68…See the Story
Eli Lilly Touts Strong Results of New Experimental Weight Loss Drug Retatrutide
50% Center coverage: 4 sources
![[Opinion] European Regulator Backs Approval Of Novo Nordisk High-Dose Wegovy - Novo Nordisk (NYSE:NVO)](/_next/image?url=https%3A%2F%2Fgrnd.b-cdn.net%2Finterest%2Fbdc66c26e4bcad2a10035733a54bc63650f2adae.jpg&w=1440&q=75)
WegovyOn Friday, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for Novo Nordisk A/S’ (NYSE:NVO) higher dose of Wegovy (semaglutide 7.2 mg). Novo Nordisk has also applied to the EMA for a single-dose device to deliver Wegovy 7.2 mg. Additionally, semaglutide 7.2 mg is currently under review in the U.S., U.K., and several other countries. Also Read: FDA Weighs Rapid Review For Eli L…See the Story
[Opinion] European Regulator Backs Approval Of Novo Nordisk High-Dose Wegovy - Novo Nordisk (NYSE:NVO)
100% Center coverage: 1 sources
